The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin
Tuberculosis (TB) remains a large-scale public health problem. Key global priorities for TB care and control include improving case-detection and detecting cases earlier, including cases of smear-negative disease. This document updates existing WHO policy on the use of molecular LPAs for detecting MTBC a...
Techniques de sonde moléculaire, Rifamycine/usage thérapeutique, Isoniazide/usage thérapeutique, Tuberculose multirésistante/diagnostic, Antituberculeux/usage thérapeutique, Isoniazide/pharmacologie, Rifampicine/pharmacologie, Mycobacterium tuberculosis/effets des médicaments et des substances chimiques, Résistance bactérienne aux médicaments, Reproductibilité des résultats